Martin Wilson serves as the General Counsel and Chief Corporate Officer, as well as Senior Vice President at Rocket Pharmaceuticals Inc., a leading biotechnology company focused on developing gene therapies for rare and devastating diseases. In his role, Wilson is responsible for overseeing the company's legal affairs, corporate governance, and strategic initiatives. His leadership has been instrumental in navigating the complex regulatory landscape of the biotech industry, ensuring compliance, and fostering a culture of innovation and integrity within the organization. Wilson brings a wealth of experience to Rocket Pharmaceuticals, having spent over two decades in the life sciences and healthcare sectors. Prior to joining Rocket, he held senior legal positions at several prominent companies, including a stint as Vice President and General Counsel at a major pharmaceutical firm, where he played a key role in numerous high-profile mergers and acquisitions, licensing agreements, and intellectual property matters. Wilson's deep understanding of the industry, combined with his strategic vision and legal expertise, has been pivotal in driving Rocket's growth and success. Under Wilson's guidance, Rocket Pharmaceuticals has made significant strides in advancing its pipeline of gene therapies, securing crucial partnerships, and expanding its global presence. His contributions have not only strengthened the company's position in the market but have also brought hope to patients and families affected by rare genetic disorders. Wilson's dedication to Rocket's mission, coupled with his outstanding leadership, continues to be a driving force behind the company's efforts to transform the lives of those in need through cutting-edge genetic medicine.